SCHEMBL2074244

SCHEMBL2074244

CC(C)N1CCN(c2cc(NC(=O)N3CCOCC3)ncn2)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
ALDH1A1 P00352 3/20 0.53
ATM Q13315 1/20 0.53
RAB9A P51151 3/20 0.51
EGFR P00533 2/20 0.51
ERBB3 P21860 2/20 0.51
KDM4E B2RXH2 3/20 0.47
MEN1 O00255 1/20 0.47
USP2 O75604 1/20 0.47
KMT2A Q03164 1/20 0.47
GAA P10253 3/20 0.44
KMO O15229 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
TP53 P04637 2/20 0.43
HSD17B10 Q99714 2/20 0.43
RECQL P46063 1/20 0.43
GSK3B P49841 2/20 0.42
DYRK1A Q13627 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2073745 0.90 SMN1; SMN2 (0.49) NPC1ALDH1A1ATMRAB9AEGFR
SCHEMBL2074790 0.88 SMN1; SMN2 (0.51) NPC1ALDH1A1ATMRAB9AEGFR
SCHEMBL2075861 0.88 SMN1; SMN2 (0.51) NPC1ALDH1A1ATMRAB9AEGFR
SCHEMBL2075431 0.85 LMNA (0.43) NPC1ALDH1A1ATMRAB9AKDM4E
SCHEMBL2074903 0.82 HRH3 (0.49) NPC1ALDH1A1ATMSMN1; SMN2
SCHEMBL2075500 0.82 SMN1; SMN2 (0.42) ALDH1A1RAB9ASMN1; SMN2RECQLGSK3B
SCHEMBL2075480 0.80 ALDH1A1 (0.51) NPC1ALDH1A1ATMRAB9AEGFR
SCHEMBL2073074 0.79 HRH4 (0.52) NPC1ALDH1A1ATMRAB9AEGFR
SCHEMBL2072344 0.79 CNR2 (0.43) ALDH1A1RAB9ASMN1; SMN2GSK3BDYRK1A
SCHEMBL2075468 0.78 EGFR (0.48) NPC1ALDH1A1ATMRAB9AEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7902184-B2 Piperazinyl pyrimidine derivatives HOFFMANN-LA ROCHE INC. (US) 2011-03-08 US disclosed